CACNA1C-AS4: A Potential Drug Target and Biomarker (G100874234)

Target Name: CACNA1C-AS4

NCBI ID: G100874234

CACNA1C-AS4

Other Name(s): CACNA1C antisense RNA 4

CACNA1C-AS4: A Potential Drug Target and Biomarker

CACNA1C-AS4 is a protein that is expressed in the central nervous system (CNS) and is involved in the regulation of synaptic plasticity. Synaptic plasticity is the ability of the nervous system to change and adapt over time, and it is a critical factor in the development and maintenance of neural circuits. CACNA1C-AS4 has been shown to play a role in the regulation of synaptic plasticity, and recent studies have suggested that it may be a potential drug target.

CACNA1C-AS4 is a member of the CACNA1C subfamily of the neurotransmitter-gated ion channels, which are a family of transmembrane proteins that play a critical role in the regulation of neurotransmitter signaling. The CACNA1C subfamily includes several different genes, including CACNA1C, CACNA1D, CACNA1E, and CACNA1F, and each of these genes encodes a different subunit of the CACNA1C channel.

CACNA1C-AS4 is a 21-kDa protein that is expressed in the CNS and is involved in the regulation of synaptic plasticity. It is a key component of the CNS synaptic plasticity machinery, which is responsible for the formation and maintenance of synaptic connections between neurons. CACNA1C-AS4 is involved in the regulation of the release of neurotransmitters, such as dopamine and glutamate, which are involved in the regulation of synaptic plasticity.

In addition to its role in synaptic plasticity, CACNA1C-AS4 is also involved in the regulation of neuronal excitability. It is a critical component of the voltage-gated ion channels, which are responsible for the regulation of neuronal excitability. CACNA1C-AS4 is involved in the regulation of the opening and closing of these channels, and its function in this regard is likely to be important for the regulation of neuronal excitability.

The potential drug target status of CACNA1C-AS4 is suggested by its structure and the results of recent studies. CACNA1C-AS4 is a transmembrane protein that is involved in the regulation of both synaptic plasticity and neuronal excitability. Its structure suggests that it is a potential drug target that could be modulated by small molecules. In addition, the results of recent studies have suggested that modifying the activity of CACNA1C-AS4 may be a promising approach for the treatment of neurological and psychiatric disorders.

In conclusion, CACNA1C-AS4 is a protein that is involved in the regulation of synaptic plasticity and neuronal excitability. Its structure and the results of recent studies suggest that it may be a potential drug target. Further research is needed to determine the full scope of CACNA1C-AS4's function and potential as a drug target.

Protein Name: CACNA1C Antisense RNA 4

The "CACNA1C-AS4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CACNA1C-AS4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets